Does ALEMTUZUMAB Cause Peripheral swelling? 227 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 227 reports of Peripheral swelling have been filed in association with ALEMTUZUMAB (Campath). This represents 1.6% of all adverse event reports for ALEMTUZUMAB.
227
Reports of Peripheral swelling with ALEMTUZUMAB
1.6%
of all ALEMTUZUMAB reports
4
Deaths
114
Hospitalizations
How Dangerous Is Peripheral swelling From ALEMTUZUMAB?
Of the 227 reports, 4 (1.8%) resulted in death, 114 (50.2%) required hospitalization, and 6 (2.6%) were considered life-threatening.
Is Peripheral swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 227 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Peripheral swelling?
ADALIMUMAB (13,837)
ETANERCEPT (12,654)
METHOTREXATE (10,632)
TOCILIZUMAB (8,030)
TOFACITINIB (7,830)
ABATACEPT (7,561)
LEFLUNOMIDE (7,254)
LENALIDOMIDE (6,364)
HYDROXYCHLOROQUINE (6,128)
RITUXIMAB (5,977)
Which ALEMTUZUMAB Alternatives Have Lower Peripheral swelling Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET